28 Oct 2016 12:30
RNS Number : 7649N
Senior PLC
28 October 2016
Pursuant to Listing Rule 9.6.14 (2), this is to notify that effective 1 November 2016, Giles Kerr, an independent non-executive Director of Senior plc, is appointed as a non-executive director of Adaptimmune Therapeutics plc (Nasdaq: ADAP) (www.adaptimmune.com).
This information is provided by RNS
The company news service from the London Stock Exchange